Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1999
11/17/1999CN1235608A Alkylated reapamycin derivatives
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1046515C Diazabicyclic neurokinin antagonists
11/17/1999CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/16/1999US5986170 Murine model for human carcinoma
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985935 Treatment and prophylaxis of diseases caused by parasites, or bacteria
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999US5985867 Treating hiv infection
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985848 Inhibitors of nucleoside metabolism
11/16/1999US5985847 Devices for administration of naked polynucleotides which encode biologically active peptides
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985321 Soft gelatin capsule manufacture
11/16/1999US5985289 Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
11/16/1999US5985284 To protect against mucosal infection with shigella.
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
11/16/1999US5985272 Human myeloperoxidase and its therapeutic application
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985264 IL-12 Stimulation of Neonatal immunity
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057274A1 Human protease associated proteins
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057148A1 Melanocortin 1 receptor selective compounds
11/11/1999WO1999057144A2 Human transcriptional regulator molecules
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999056777A1 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE FcηRI RECEPTOR
11/11/1999WO1999056776A2 Adjuvant composition and methods for its use
11/11/1999WO1999056775A1 Use of interleukin-18 as vaccine adjuvant
11/11/1999WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements
11/11/1999WO1999056764A1 Method for preventing or treating a human immunodeficiency virus infection
11/11/1999WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999WO1999045031A9 Cd147 binding molecules as therapeutics
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999WO1999040073A3 Tryptase inhibitors
11/11/1999WO1999030736A3 Methods to treat undesirable immune responses
11/11/1999WO1999029863A9 Human interferon-epsilon: a type i interferon
11/11/1999WO1999027105A3 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/11/1999CA2331607A1 Reversal of proinflammatory response by ligating the macrophage fc.gamma.ri receptor
11/11/1999CA2330610A1 Adjuvant composition and methods for its use
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2328059A1 Use of interleukin-18 as vaccine adjuvant
11/11/1999CA2327550A1 Melanocortin 1 receptor selective compounds
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2327263A1 Human protease associated proteins
11/11/1999CA2327259A1 Human transcriptional regulator molecules
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
11/10/1999EP0955295A1 Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
11/10/1999EP0955059A2 Vaccines containing a saponin and a sterol
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954594A2 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
11/10/1999EP0954576A2 Cd16-ii variants
11/10/1999EP0954564A1 Methods for generating cytotoxic t cells in vitro
11/10/1999EP0954534A1 Pasteurization of immunoglobulin solutions
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954530A1 Immunomodulatory peptides of vespid antigen 5
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954325A1 Method for the specific immunoadsorption of selected pathogenic factors
11/10/1999EP0954324A1 Cyclic peptide vaccines for treatment and prevention of diabetes
11/10/1999EP0954322A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
11/10/1999EP0954318A1 A nasal spray containing an intranasal steroid and an antihistamine
11/10/1999EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
11/10/1999EP0954310A1 Synergistic composition comprising rapamycin and calcitriol
11/10/1999EP0863873B1 Indole carbamates as leukotriene antagonists
11/10/1999CN1234834A Methods for preventing graft rejection in transplantation and for producing universal gene therapy host cell
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234805A ICE inhibiting peptides
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046274C Isoxazoline compounds as antinflammatory agents
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981708 Rodent polypeptide which is an autocrine growth factor; for augmenting growth of hematopoeitic stem cells; for antitumor agents to control tumor cell growth
11/09/1999US5981701 Tumor necrosis factor inhibitory protein and its purification
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
1 ... 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 ... 1172